Latest Placental growth factor Stories
Cardiologists have discovered biomarkers that can be used to develop a screening test to detect Peripartum Cardiomyopathy (PPCM), a life-threatening disorder that is the primary cause of mortality in pregnant women in developing countries.
Small for their gestational age, infants account for approximately 10 percent of births, and increased maternal risk for ischemic heart disease in women.
A novel therapy that reduces elevated blood levels of a potentially toxic protein in women with preeclampsia, a dangerous complication of pregnancy, may someday address the therapeutic dilemma posed by the condition â€“ balancing life-threatening risks to the mother with the dangers that early delivery poses to an immature fetus.
Researchers may have identified a promising novel diagnostic biomarker for ectopic pregnancy.
By Gustafsdottir, Sigrun M Wennstrom, Stefan; Fredriksson, Simon; Schallmeiner, Edith; Hamilton, Andrew D; Sebti, Said M; Landegren, Ulf BACKGROUND: Improved methods are required to screen drug candidates for their influences on protein interactions.
- To swell, as grain or wood with water.